Bisoprolol detailed information: Difference between revisions
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
No edit summary |
||
Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{Bisoprolol}} | |||
{{CMG}}; {{AE}} {{SS}} | |||
}} | |||
{{CMG}} | |||
'''''For patient information about Bisoprolol, click [[Bisoprolol (patient information)|here]]''''' | |||
{{SB}} {{ZEBETA}} | |||
==Overview== | ==Overview== | ||
'''Bisoprolol''' is a drug belonging to the group of [[beta blocker]]s, a class of drugs used primarily in [[cardiovascular disease]]s. More specifically, it is a selective type β1 [[adrenergic receptor]] blocker <ref>[http://www.fass.se/LIF/produktfakta/artikel_produkt.jsp?NplID=20040326000029&DocTypeID=7&UserTypeID=2 FASS (Swedish official drug catalog) (labeling as "Selektiv beta1-blockerare" = selective beta1-blocker)]</ref>. | '''Bisoprolol''' is a drug belonging to the group of [[beta blocker]]s, a class of drugs used primarily in [[cardiovascular disease]]s. More specifically, it is a selective type β1 [[adrenergic receptor]] blocker <ref>[http://www.fass.se/LIF/produktfakta/artikel_produkt.jsp?NplID=20040326000029&DocTypeID=7&UserTypeID=2 FASS (Swedish official drug catalog) (labeling as "Selektiv beta1-blockerare" = selective beta1-blocker)]</ref>. | ||
==Category== | |||
Cardiovascular Drugs:Beta blockers | |||
==FDA Package Insert== | |||
'''| [[Bisoprolol indications and usage|Indications and Usage]]''' | |||
Bisoprolol | '''| [[Bisoprolol dosage and administration|Dosage and Administration]]''' | ||
'''| [[Bisoprolol dosage forms and strengths|Dosage Forms and Strengths]]''' | |||
'''| [[Bisoprolol contraindications|Contraindications]]''' | |||
'''| [[Bisoprolol warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Bisoprolol adverse reactions|Adverse Reactions]]''' | |||
'''| [[Bisoprolol drug interactions|Drug Interactions]]''' | |||
'''| [[Bisoprolol use in specific populations|Use in Specific Populations]]''' | |||
'''| [[Bisoprolol overdosage|Overdosage]]''' | |||
'''| [[Bisoprolol description|Description]]''' | |||
'''| [[Bisoprolol clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Bisoprolol nonclinical toxicology|Nonclinical Toxicology]]''' | |||
'''| [[Bisoprolol clinical studies|Clinical Studies]]''' | |||
'''| [[Bisoprolol how supplied storage and handling|How Supplied/Storage and Handling]]''' | |||
'''| [[Bisoprolol patient counseling information|Patient Counseling Information]]''' | |||
'''| [[Bisoprolol labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{ | |||
[[Category:Beta blockers]] | [[Category:Beta blockers]] | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[de:Bisoprolol]] | [[de:Bisoprolol]] | ||
Line 47: | Line 49: | ||
[[nl:Bisoprolol]] | [[nl:Bisoprolol]] | ||
[[ru:Бисопролол]] | [[ru:Бисопролол]] | ||
Revision as of 02:20, 4 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Bisoprolol, click here
Synonyms / Brand Names: Template:ZEBETA
Overview
Bisoprolol is a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases. More specifically, it is a selective type β1 adrenergic receptor blocker [1].
Category
Cardiovascular Drugs:Beta blockers
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages